Status:
COMPLETED
Tolerability of a Novel Spectacle Design With Reduced Peripheral Contrast
Lead Sponsor:
SightGlass Vision, Inc.
Conditions:
Myopia
Eligibility:
All Genders
6-12 years
Phase:
NA
Brief Summary
Prospective, randomized, subject-masked 3-arm clinical study to assess the pediatric acceptability across three iterations of a novel spectacle lens design.
Detailed Description
This feasibility study was conducted to assess the performance of three experimental spectacle lens designs (spectacle lenses) in children between 6 and 9 years of age with myopia.
Eligibility Criteria
Inclusion
- Ages between 6 and 12 years
- Myopia between -1.00 and -4.00 D
Exclusion
- Participating in any clinical or other research study
- Contact lens wearer
Key Trial Info
Start Date :
May 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 19 2018
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT03761758
Start Date
May 1 2018
End Date
July 19 2018
Last Update
December 3 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre for Ocular Research & Education
Waterloo, Ontario, Canada, N2L 3G1